MarketInOut Stock Screener Log In | Sign Up
 

Processa Pharmaceuticals Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
Processa Pharmaceuticals Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization5.01 mln
Float2.36 mln
Earnings Date11/06/2026

Piotroski F-Score

3 / 9
Below average

Relative Strength

95 / 100
Top performer

ROE

-340
Deeply negative

ROA

-223
Deeply negative

Business Description

Processa Pharmaceuticals is a Florida-based clinical-stage drug development company focused on improving existing cancer treatments by modifying already-approved drugs to make them safer and more effective. Rather than creating entirely new compounds, the company refines how drugs are processed and distributed by the body while preserving their ability to target cancer cells. Beyond oncology, Processa is also developing treatments for kidney diseases and digestive disorders. Founded in 2015, the company works through licensing partnerships with several pharmaceutical organizations to advance its pipeline.

Key Fundamentals

EPS-4.33
ROE-340
ROIC-948
ROA-223
Interest Cover-6,419
EBITDA, mln-13.44
EV / EBITDA-0.32
EV / EBIT-0.32

Quote Details

Last 1.81
Change -0.05 (-2.69%)
Open 1.76
Volume 35,044
Turnover 63,430
Average Volume 183,139

Financial Strength

Piotroski F-Score 3 / 9
Short Ratio0.16
Short % of Float0.17

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 7.1% 88 / 100   
1 Month -2.16% 57 / 100   
2 Months -18.47% 29 / 100   
6 Months -39.26% 20 / 100   
1 Year -73.99% 8 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog